St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
Explore linked clinical trials.169 results · Page 1 of 7
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Stem Cell Mobilization and Apheresis for Life-threatening Blood Disorders | Bone Marrow Failure Disorders, Hemic and Lymphatic Diseases, bone marrow disorder, hematologic disorder | Recruiting | Phase 1 | 2026-10-06 | NCT07585136 | |
| Study of Selinexor and Venetoclax in Combination With Chemotherapy in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute biphenotypic leukemia, acute myeloid leukemia, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoproliferative syndrome, myeloid leukemia, neoplasm | Active, not recruiting | Phase 1 | 2026-10-06 | NCT04898894 | |
| Molecular Characterization of Neuroblastic Tumor: Correlation With Clinical Outcome | Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Neuroectodermal Tumors, Primitive, Neuroectodermal Tumors, Primitive, Peripheral, epithelial neoplasm, neoplasm, neuroblastoma, neuroepithelial neoplasm, primitive neuroectodermal tumor | Recruiting | Not stated | 2026-10-05 | NCT00588068 | |
| A Registry of Cases of Spinal Muscular Atrophy | central nervous system disorder, motor neuron disorder, nervous system disorder, neurodegenerative disease, neuromuscular disease, spinal cord disorder, spinal muscular atrophy | Recruiting | Not stated | 2026-09-30 | NCT07805278 | |
| An Open-Label Intervention Trial to Reduce Senescence and Improve Frailty in Adult Survivors of Childhood Cancer | Frailty, Pathologic Processes, Pathological Conditions, Signs and Symptoms, childhood malignant neoplasm, neoplasm | Active, not recruiting | Phase 2 | 2026-09-30 | NCT04733534 | |
| Clinical Assessment and Targeted Imaging to Characterize High-Risk Atherosclerotic Cardiovascular Disease of Survivors in SJLIFE | Arterial Occlusive Diseases, arteriosclerosis disorder, atherosclerosis, atherosclerotic cardiovascular disease, cardiovascular disorder, vascular disorder | Recruiting | Not stated | 2026-09-24 | NCT07594392 | |
| Cognitive Rehabilitation for Survivors of Childhood Medulloblastoma Using Real Time Hemodynamic Neurofeedback | Medulloblastoma, Childhood, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Neuroectodermal Tumors, Primitive, epithelial neoplasm, glioma, medulloblastoma, neoplasm, neuroepithelial neoplasm, primitive neuroectodermal tumor | Recruiting | Not applicable | 2026-09-23 | NCT07830134 | |
| Obesity Treatment With Phentermine-Topiramate ER in AYA Surviving Leukemia and Lymphoma | Acute Lymphoblastic Leukemia in Remission; Cancer Survivorship; Hodgkin Lymphoma in Remission; Non-Hodgkin Lymphoma in Remission | Not yet recruiting | Phase 2 | 2026-09-23 | NCT07790913 | |
| Using Bioimpedance Analysis to Monitor Fluid Status in Children | Edema, Pathological Conditions, Signs and Symptoms, Signs and Symptoms | Not yet recruiting | Not stated | 2026-09-22 | NCT07834710 | |
| A Phase II Trial of Intensity-Modulated Proton Therapy for Incompletely Resected Craniopharyngioma and Observation for Craniopharyngioma After Radical Resection | Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, brain disorder, central nervous system cancer, central nervous system disorder, craniopharyngioma, neoplasm, nervous system disorder, primitive neuroectodermal tumor | Active, not recruiting | Phase 2 | 2026-09-22 | NCT02792582 | |
| Real World Asparaginase Therapy Toxicity | Chemically-Induced Disorders, Drug Toxicity, Drug-Related Side Effects and Adverse Reactions, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Precursor Cell Lymphoblastic Leukemia-Lymphoma, acute biphenotypic leukemia, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoproliferative syndrome, neoplasm | Not yet recruiting | Not stated | 2026-09-17 | NCT07008027 | |
| Imaging Skeletal Muscle Mitochondrial OXPHOS Activity In Acute Lymphoblastic Leukemia Survivors | Hemic and Lymphatic Diseases, Muscle Weakness, Neoplasms by Histologic Type, Neurologic Manifestations, Neuromuscular Manifestations, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Signs and Symptoms, childhood malignant neoplasm, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoproliferative syndrome, muscle tissue disorder, musculoskeletal system disorder, neoplasm, nervous system disorder | Recruiting | Not applicable | 2026-09-17 | NCT06819475 | |
| A Study of Venetoclax in Combination With Conventional Chemotherapy in Pediatric Patients With Acute Myeloid Leukemia | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasm | Recruiting | Phase 2 | 2026-09-17 | NCT05955261 | |
| Liver Biopsy Following Gene Therapy For Hemophilia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, X-linked disease, blood coagulation disease, coagulation protein disease, hematologic disorder, hemophilia A, hemophilia B, hemorrhagic disease, hereditary disease, inherited blood coagulation disorder | Not yet recruiting | Not stated | 2026-09-17 | NCT05932914 | |
| Muscle Aging Phenotypes in Childhood Cancer Survivors | Atrophy, Muscle Weakness, Neurologic Manifestations, Neuromuscular Manifestations, Pathologic Processes, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Sarcopenia, Signs and Symptoms, muscle tissue disorder, muscular atrophy, musculoskeletal system disorder, nervous system disorder | Recruiting | Not stated | 2026-09-16 | NCT07531498 | |
| Haploidentical HCT for Severe Aplastic Anemia | Bone Marrow Failure Disorders, Hemic and Lymphatic Diseases, anemia, aplastic anemia, bone marrow disorder, hematologic disorder | Recruiting | Phase 2 | 2026-09-16 | NCT04558736 | |
| Haplocompatible Transplant Using TCRα/β Depletion Followed by CD45RA-Depleted Donor Lymphocyte Infusions for Severe Combined Immunodeficiency (SCID) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, DNA repair disease, Infant, Newborn, Diseases, Nutritional and Metabolic Diseases, Primary Immunodeficiency Diseases, graft versus host disease, hereditary disease, immune system disorder, inborn error of immunity, metabolic disease, severe combined immunodeficiency | Active, not recruiting | Phase 1 / Phase 2 | 2026-09-16 | NCT03597594 | |
| A Prospective Trial of Dalbavancin-Based Prophylaxis in Children and Adolescents With High-Risk Leukemia | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasm | Recruiting | Phase 1 | 2026-09-15 | NCT06810583 | |
| Long Term Follow-Up Study for Individuals With Hemoglobin Disorders After Hematopoietic Cell Transplant or Gene Therapy | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, hematologic disorder, hereditary disease, inherited hemoglobinopathy | Recruiting | Not stated | 2026-09-15 | NCT06646640 | |
| Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma | Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Neuroectodermal Tumors, Primitive, brain disorder, central nervous system cancer, central nervous system disorder, epithelial neoplasm, glioma, medulloblastoma, neoplasm, nervous system disorder, neuroepithelial neoplasm, primitive neuroectodermal tumor | Recruiting | Phase 2 | 2026-09-15 | NCT05535166 | |
| Evaluation of Hippocampal-Avoidance Using Proton Therapy in Low-Grade Glioma | Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, astrocytoma (excluding glioblastoma), diffuse astrocytoma, epithelial neoplasm, ganglioglioma, glioma, neoplasm, neuroepithelial neoplasm, optic pathway glioma, pilocytic astrocytoma, pilomyxoid astrocytoma, primitive neuroectodermal tumor | Active, not recruiting | Not applicable | 2026-09-15 | NCT04065776 | |
| TCRαβ-depleted Progenitor Cell Graft With Additional Memory T-cell DLI, Plus Selected Use of Blinatumomab, in Naive T-cell Depleted Haploidentical Donor Hematopoietc Cell Transplantation for Hematologic Malignancies | Chronic Disease, Disease Attributes, Hemic and Lymphatic Diseases, Hodgkins lymphoma, Leukemia, Large Granular Lymphocytic, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Myeloproliferative Disorders, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Precursor Cell Lymphoblastic Leukemia-Lymphoma, T-cell leukemia, acute lymphoblastic leukemia, acute myeloid leukemia, aggressive NK-cell leukemia, bone marrow disorder, hematologic disorder, immune system disorder, immunoproliferative disorder, juvenile myelomonocytic leukemia, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoma, lymphoproliferative syndrome, myelodysplastic syndrome, myelodysplastic/myeloproliferative disease, myeloid leukemia, neoplasm | Active, not recruiting | Phase 2 | 2026-09-15 | NCT03849651 | |
| SJ901: Evaluation of Mirdametinib in Children, Adolescents, and Young Adults With Low-Grade Glioma | Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, astrocytoma (excluding glioblastoma), brain disorder, central nervous system cancer, central nervous system disorder, central neurocytoma, epithelial neoplasm, ganglioglioma, glioma, low grade glioma, neoplasm, nervous system disorder, neuroepithelial neoplasm, oligodendroglioma, primitive neuroectodermal tumor | Recruiting | Phase 1 / Phase 2 | 2026-09-11 | NCT04923126 | |
| Transcranial Photobiomodulation Treatment in Patients With Sickle Cell Disease | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, anemia, familial hemolytic anemia, hematologic disorder, hemolytic anemia, hereditary disease, inherited hemoglobinopathy, sickle cell disease | Not yet recruiting | Not applicable | 2026-09-10 | NCT06797583 | |
| Methylphenidate to Address Attention and Executive Deficits Among Children With Sickle Cell Disease | Cognition Disorders, Cognitive Dysfunction, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, anemia, attention deficit hyperactivity disorder, inattentive type, cognitive disorder, familial hemolytic anemia, hematologic disorder, hemolytic anemia, hereditary disease, inherited hemoglobinopathy, neurodevelopmental disorder, oppositional defiant disorder, psychiatric disorder, sickle cell disease | Recruiting | Phase 1 | 2026-09-09 | NCT07226219 |